Literature Mining and Mechanistic Graphical Modelling to Improve mRNA Vaccine Platforms
暂无分享,去创建一个
C. Priami | E. Domenici | D. Medini | L. Marchetti | S. Parolo | G. Selvaggio | L. Leonardelli | Giuseppe Lofano | Emilio Siena | Haifeng Song | Stefano Giampiccolo | Danilo Tomasoni | D. Tomasoni
[1] Fei Wang,et al. Recent advances in biomedical literature mining , 2020, Briefings Bioinform..
[2] Corrado Priami,et al. High-Precision Biomedical Relation Extraction for Reducing Human Curation Efforts in Industrial Applications , 2020, IEEE Access.
[3] I. Ferlenghi,et al. Mannosylation of LNP results in improved potency for self-amplifying RNA (SAM) vaccines. , 2019, ACS infectious diseases.
[4] E. Frigimelica,et al. Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines. , 2019, Vaccine.
[5] C. Zurla,et al. Visualization of early events in mRNA vaccine delivery in non-human primates via PET–CT and near-infrared imaging , 2019, Nature Biomedical Engineering.
[6] Christian Simon,et al. BioReader: a text mining tool for performing classification of biomedical literature , 2019, BMC Bioinformatics.
[7] Indra Neil Sarkar,et al. Machine learning approach to literature mining for the genetics of complex diseases , 2019, Database J. Biol. Databases Curation.
[8] D. Weissman,et al. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses , 2018, The Journal of experimental medicine.
[9] D. Weissman,et al. mRNA vaccines — a new era in vaccinology , 2018, Nature Reviews Drug Discovery.
[10] E. Ramanculov,et al. Recombinant Vaccinia virus-coded interferon inhibitor B18R: Expression, refolding and a use in a mammalian expression system with a RNA-vector , 2017, PloS one.
[11] Ö. Türeci,et al. Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion Proteins , 2017, Human gene therapy.
[12] Kimberly J. Hassett,et al. Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells , 2017, Front. Immunol..
[13] M. Fotin‐Mleczek,et al. Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines , 2017, npj Vaccines.
[14] Kimberly J. Hassett,et al. Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[15] Vinaitheerthan Renganathan,et al. Text Mining in Biomedical Domain with Emphasis on Document Clustering , 2017, Healthcare informatics research.
[16] Jason C Debasitis,et al. Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design , 2017, The Journal of Immunology.
[17] Pengpeng Xia,et al. RNA sensors of the innate immune system and their detection of pathogens , 2017, IUBMB life.
[18] J. Rosenecker,et al. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems , 2017, Gene Therapy.
[19] M. Fotin‐Mleczek,et al. Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response , 2017, Journal of Translational Medicine.
[20] Daniel G. Anderson,et al. Materials for non-viral intracellular delivery of messenger RNA therapeutics. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[21] S. Bertholet,et al. Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge , 2016, PloS one.
[22] J. Ulmer,et al. Recent innovations in mRNA vaccines. , 2016, Current opinion in immunology.
[23] P. Mason,et al. Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin , 2015, Journal of Virology.
[24] C. Buonsanti,et al. CD8 T‐cell priming upon mRNA vaccination is restricted to bone‐marrow‐derived antigen‐presenting cells and may involve antigen transfer from myocytes , 2015, Immunology.
[25] T. Schlake,et al. Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.
[26] H. Liao,et al. Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion. , 2015, The Journal of infectious diseases.
[27] G. Vanham,et al. Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[28] S. Akira,et al. Activation of MDA5 Requires Higher-Order RNA Structures Generated during Virus Infection , 2009, Journal of Virology.
[29] Hiroki Kato,et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[30] Gunther Hartmann,et al. 5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.
[31] Sophia Ananiadou,et al. Text Mining for Biology And Biomedicine , 2005 .
[32] Shizuo Akira,et al. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.